Jazz Pharmaceuticals Goodwill and Intangible Assets 2010-2024 | JAZZ
Jazz Pharmaceuticals goodwill and intangible assets for the quarter ending June 30, 2024 were $6.815B, a 8.5% decline year-over-year.
- Jazz Pharmaceuticals goodwill and intangible assets for 2023 were $7.171B, a 4.22% decline from 2022.
- Jazz Pharmaceuticals goodwill and intangible assets for 2022 were $7.487B, a 16.62% decline from 2021.
- Jazz Pharmaceuticals goodwill and intangible assets for 2021 were $8.98B, a 184.77% increase from 2020.